SAN DIEGO, Jan. 6 /PRNewswire/ -- Accumetrics, Inc. has appointed Andrew Chisholm to the position of Vice President, Sales and Corporate Accounts.
"Andrew brings the right mix of energy and expertise to Accumetrics. His experience will help us reach the next level in terms of our market penetration," says Timothy I. Still, President and CEO at Accumetrics. "His knowledge of the medical diagnostics industry and his relationships with distributors make him a key component of our growth strategy in 2009 and beyond."
Prior to joining Accumetrics, Mr. Chisholm served as Vice President of Sales and Corporate Accounts at Hemosense, a medical diagnostics company located in San Jose, California which was acquired by Inverness Medical in November 2007. Prior to that, Mr. Chisholm managed sales and marketing activities with increasing responsibilities at Bayer Healthcare, Henry Schein, Johnson & Johnson and the Eastman Kodak Company.
About Accumetrics (www.accumetrics.com):
Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.
Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.
The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.
CONTACT: Jules Abraham Lippert Heilshorn & Associates 212-838-3777 firstname.lastname@example.org Timothy I. Still Accumetrics email@example.com
|SOURCE Accumetrics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved